HE POWER OF CTMS


INTEROPER B I Y, AND COLLABORND COLLABORATITION


I TEGRAT ON,TION, INTEROPERABIL


N EGRA A IL T


THE POWER OF CTMS


HEALT HEAL


HEAL H CS IENCES IENCE


CTM ENG


TH


TH M C


TM


ENG Kar


PORTING


TY, AL AL


om he he lthsalths s.com s.co


HEALTH SCIENCES


LATE PHASE DEVELOPMENT


MAXIMIZING THE VALUE OF REAL WORLD DATA


ENABLING OBSERVATIONAL AND LONG-TERM


POST-MARKETING STUDIES Scott Dixon, Oracle


OPTIMIZING PATIENT-REPORTED OUTCOMES IN


LATE-PHASE STUDIES— START AT THE END


Eric Gemmen and Louise Parmenter, Quintiles


PATIENT REGISTRIES, REAL-LIFE SETTINGS—THE USE OF PREGNANCY REGISTRIES IN LATE PHASE DEVELOPMENT Deborah Covington, PPD


touchhealthsciences.com


Connectivity, interoperability and convergence embody the new digital ecosystem in the biopharmaceutical and healthcare industries. This series of expert-led reports, published in collaboration with Oracle Health Sciences, provides unique insights on the key issues affecting the new healthcare paradigm and the biopharmaceutical R&D value chain. With contributions from Merck, GlaxoSmithKline, Pfizer, Amgen, sanofi aventis, Quintiles, PPD and other principal industry leaders, these reports set the future agenda for healthcare and life sciences executives.


Oracle Corporation


500 Oracle Parkway, Redwood Shores, CA 94065 hsgbu_ww@oracle.com


www.oracle.com/healthsciences HEALTH SCIENCES


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20